Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial for efficacy and safety of cilostazol on the progression of symptomatic intracranial stenosis comparing clopidogrel

X
Trial Profile

Trial for efficacy and safety of cilostazol on the progression of symptomatic intracranial stenosis comparing clopidogrel

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Apr 2012

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cilostazol (Primary) ; Aspirin; Clopidogrel
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms TOSS-2; TOSS-II
  • Most Recent Events

    • 29 Mar 2012 Substudy results presented at the 16th International Symposium on Atherosclerosis.
    • 12 Jan 2010 Actual end date (Jan 2009) and actual number of patients (457) added as reported by ClinicalTrials.gov.
    • 12 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top